Lee's Pharmaceutical International Limited - Net Worth and Insider Trading

Lee's Pharmaceutical International Limited Net Worth

The estimated net worth of Lee's Pharmaceutical International Limited is at least $420 Million dollars as of 2025-06-04. Lee's Pharmaceutical International Limited is the 2101 Beneficial owner of Zhaoke Ophthalmology Ltd and owns about 138,192,000 shares of Zhaoke Ophthalmology Ltd (HKSE:06622) stock worth over $420 Million. Details can be seen in Lee's Pharmaceutical International Limited's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lee's Pharmaceutical International Limited has not made any transactions after 2021-04-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Lee's Pharmaceutical International Limited

Lee's Pharmaceutical International Limited Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lee's Pharmaceutical International Limited owns 1 companies in total, including Zhaoke Ophthalmology Ltd (HKSE:06622) .

Click here to see the complete history of Lee's Pharmaceutical International Limited’s form 4 insider trades.

Insider Ownership Summary of Lee's Pharmaceutical International Limited

Ticker	Company	Transaction Date	Type of Owner
HKSE:06622	Zhaoke Ophthalmology Ltd	2021-04-29	2101 Beneficial owner

Lee's Pharmaceutical International Limited Latest Holdings Summary

Lee's Pharmaceutical International Limited currently owns a total of 1 stock. Lee's Pharmaceutical International Limited owns 138,192,000 shares of Zhaoke Ophthalmology Ltd (HKSE:06622) as of April 29, 2021, with a value of $420 Million.

Latest Holdings of Lee's Pharmaceutical International Limited

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:06622	Zhaoke Ophthalmology Ltd	2021-04-29	138,192,000	3.04	420,103,680

Holding Weightings of Lee's Pharmaceutical International Limited

Lee's Pharmaceutical International Limited Form 4 Trading Tracker

According to the SEC Form 4 filings, Lee's Pharmaceutical International Limited has made a total of 2 transactions in Zhaoke Ophthalmology Ltd (HKSE:06622) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Zhaoke Ophthalmology Ltd is the sale of 0 shares on April 29, 2021, which brought Lee's Pharmaceutical International Limited around $0.

Insider Trading History of Lee's Pharmaceutical International Limited

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lee's Pharmaceutical International Limited Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Lee's Pharmaceutical International Limited Ownership Network

Ownership Network List of Lee's Pharmaceutical International Limited

No Data

Ownership Network Relation of Lee's Pharmaceutical International Limited

Lee's Pharmaceutical International Limited Owned Company Details

What does Zhaoke Ophthalmology Ltd do?

Who are the key executives at Zhaoke Ophthalmology Ltd?

Lee's Pharmaceutical International Limited is the 2101 Beneficial owner of Zhaoke Ophthalmology Ltd. Other key executives at Zhaoke Ophthalmology Ltd include 2201 Interest of corporation controlled by you MAK Siu Hang Viola , 2201 Interest of corporation controlled by you Gic Private Limited , and 2101 Beneficial owner Coyote Investment Pte Ltd .

Zhaoke Ophthalmology Ltd (HKSE:06622) Insider Trades Summary

Over the past 18 months, Lee's Pharmaceutical International Limited made no insider transaction in Zhaoke Ophthalmology Ltd (HKSE:06622). Other recent insider transactions involving Zhaoke Ophthalmology Ltd (HKSE:06622) include a net sale of 1,100,500 shares made by Gic Private Limited , a net sale of 2,314,750 shares made by MAK Siu Hang Viola , and a net purchase of 2,822,000 shares made by Fil Limited .

In summary, during the past 3 months, insiders sold 0 shares of Zhaoke Ophthalmology Ltd (HKSE:06622) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,111,250 shares of Zhaoke Ophthalmology Ltd (HKSE:06622) were sold and 11,288,000 shares were bought by its insiders, resulting in a net purchase of 7,176,750 shares.

Zhaoke Ophthalmology Ltd (HKSE:06622)'s detailed insider trading history can be found in Insider Trading Tracker table.

Zhaoke Ophthalmology Ltd Insider Transactions

No Available Data

Lee's Pharmaceutical International Limited Mailing Address

Above is the net worth, insider trading, and ownership report for Lee's Pharmaceutical International Limited. Currently GuruFocus does not have mailing address information for Lee's Pharmaceutical International Limited.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.